Regional age-related atrophy after screening for preclinical alzheimer disease

14Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Brain atrophy occurs in aging even in the absence of dementia, but it is unclear to what extent this is due to undetected preclinical Alzheimer disease. Here we examine a cross-sectional cohort (ages 18-88) free from confounding influence of preclinical Alzheimer disease, as determined by amyloid PET scans and three years of clinical evaluation post-imaging. We determine the regional strength of age-related atrophy using linear modeling of brain volumes and cortical thicknesses with age. Age-related atrophy was seen in nearly all regions, with greatest effects in the temporal lobe and subcortical regions. When modeling age with the estimated derivative of smoothed aging curves, we found that the temporal lobe declined linearly with age, subcortical regions declined faster at later ages, and frontal regions declined slower at later ages than during midlife. This age-derivative pattern was distinct from the linear measure of age-related atrophy and significantly associated with a measure of myelin. Atrophy did not detectably differ from a preclinical Alzheimer disease cohort when age ranges were matched.

Cite

CITATION STYLE

APA

Koenig, L. N., LaMontagne, P., Glasser, M. F., Bateman, R., Holtzman, D., Yakushev, I., … Benzinger, T. L. S. (2022). Regional age-related atrophy after screening for preclinical alzheimer disease. Neurobiology of Aging, 109, 43–51. https://doi.org/10.1016/j.neurobiolaging.2021.09.010

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free